RXST
RxSight, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
RxSight, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
No other changes.
No other changes.
Annual filing, covered
10-K parsed · Feb 25 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 25 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Same SIC code · 5
Same SEC industry code: Cooper Companies, Inc., Warby Parker Inc., National Vision Holdings, Inc. and 2 more; of RxSight, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 5
Same SEC industry code: Cooper Companies, Inc., Warby Parker Inc., National Vision Holdings, Inc. and 2 more; of RxSight, Inc.'s 6 closest co-movers, none share that code.
−3.34%
vs ±51.3% implied · ×0.07
shaded = implied · ▲▼ = realized
RxSight, Inc.
4.69
−0.11 · −2.38%
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $27.9M | 13.96% | +81.68% |
| Millennium | $14.6M | 7.31% | +47.14% |
| No Street GP | $9.9M | 4.95% | +2.75% |
| Nomura | $9.6M | 4.82% | 0.00% |
| D. E. Shaw | $9.6M | 4.79% | +1.30% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $27.9M | 13.96% | +81.68% |
| Millennium | $14.6M | 7.31% | +47.14% |
| No Street GP | $9.9M | 4.95% | +2.75% |
| Nomura | $9.6M | 4.82% | 0.00% |
| D. E. Shaw | $9.6M | 4.79% | +1.30% |
Bull1
Bear2
Largest filed tie
—
—
—
Expected move
No implied move.